X4 Pharmaceuticals, Inc.

MA · United States · Reporting entity ID 100001448327

Total reported 2019–2025

$3.09M

#877 of 2,960 reporting companies — 0% of all reported industry payments

$393K in general payments across 273 records, plus $2.70M in research funding across 419 records.

How it breaks down

General payments $393,064

Research funding $2,698,172

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.